ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,647Medicare Part D Prescriptions Filled, Including Refills

Rank: 26 out of 2343

$1.46M Total Retail Price of All Prescriptions

Rank: 26 out of 2343

878 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 878 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

8% of this provider’s 878 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

0% of this provider’s 23,634 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
METOPROLOL TARTRATE 1,152 1,070 1 7
AMLODIPINE BESYLATE 1,115 1,059 2 5
LEVOTHYROXINE SODIUM 987 884 3 2
WARFARIN SODIUM 805 777 4 8
SIMVASTATIN 746 711 5 1
FUROSEMIDE 720 685 6 6
LISINOPRIL 691 642 7 3
OMEPRAZOLE 644 590 8 4
ATORVASTATIN CALCIUM 610 578 9 10
METOPROLOL SUCCINATE 471 448 10 14
ATENOLOL 454 425 11 12
CITALOPRAM HBR 383 365 12 17
LOSARTAN POTASSIUM 369 335 13 19
METFORMIN HCL 332 291 14 9
KLOR-CON M20 316 281 15 44
DONEPEZIL HCL 303 293 16 21
GABAPENTIN 302 259 17 16
POTASSIUM CHLORIDE 288 264 18 18
PRAVASTATIN SODIUM 265 240 19 15
TRAMADOL HCL 259 227 20 25
SERTRALINE HCL 232 194 21 20
HYDROCHLOROTHIAZIDE 228 211 22 11
HYDROCODONE-ACETAMINOPHEN 221 183 S3 23 13
JANTOVEN 211 211 24 81
CLONIDINE HCL 210 186 25 70
ZOLPIDEM TARTRATE 208 176 26 24
PANTOPRAZOLE SODIUM 206 197 27 22
TRIAMTERENE-HCTZ 204 188 28 57
DIGOXIN 200 191 29 35
TAMSULOSIN HCL 192 192 30 29
CARBIDOPA-LEVODOPA 191 181 31 85
PREDNISONE 189 178 32 37
GLIMEPIRIDE 184 166 33 45
CLOPIDOGREL 178 157 34 26
SPIRONOLACTONE 174 152 35 65
FAMOTIDINE 172 172 36 60
ALLOPURINOL 172 165 36 31
NAMENDA 168 168 38 36
QUETIAPINE FUMARATE 154 146 39 77
LANTUS SOLOSTAR 153 129 40 101
PEN NEEDLE 150 126 41 119
CRESTOR 148 128 42 30
DIOVAN 143 143 43 23
MIRTAZAPINE 135 108 44 41
LIPITOR 127 126 45 78
HUMALOG 125 118 46 131
VERAPAMIL ER 124 113 47 95
PLAVIX 120 112 48 38
LYRICA 117 108 49 135
PAROXETINE HCL 115 101 50 66
POLYETHYLENE GLYCOL 3350 113 112 51 54
JANUVIA 112 96 52 50
ADVAIR DISKUS 109 99 53 34
NYSTOP 101 100 54 196
GLIPIZIDE 98 87 55 56
NOVOLOG 94 87 56 110
SPIRIVA 94 86 56 48
TRAZODONE HCL 93 92 58 53
PROAIR HFA 92 87 59 86
OXYCODONE-ACETAMINOPHEN 92 90 S2 59 49
CEFUROXIME 89 79 61 193
NEXIUM 86 78 62 33
FLUTICASONE PROPIONATE 84 83 63 46
LEVOFLOXACIN 83 74 64 106
AMOXICILLIN 82 80 65 118
SYNTHROID 81 77 66 40
LANTUS 80 78 67 51
MECLIZINE HCL 80 65 67 103
CYMBALTA 80 65 67 74
ISOSORBIDE MONONITRATE ER 80 62 67 32
CEPHALEXIN 76 71 71 111
AMIODARONE HCL 75 75 72 158
BENICAR 74 74 73 93
AMLODIPINE BESYLATE-BENAZEPRIL 74 64 73 59
HYDRALAZINE HCL 73 72 75 92
LIDODERM 72 71 76 130
ALPRAZOLAM 71 71 77 305
LEVETIRACETAM 69 69 78 104
ZETIA 68 45 79 52
DIVALPROEX SODIUM 68 39 79 105
RISPERIDONE 67 59 81 61
BUSPIRONE HCL 67 56 81 146
GLIPIZIDE XL 66 61 83 84
TOPROL XL 66 66 83 426
CIPROFLOXACIN HCL 65 61 85 72
DILTIAZEM 24HR ER 65 64 85 76
NIFEDIPINE ER 64 64 87 89
FLOVENT HFA 64 52 87 213
OXYBUTYNIN CHLORIDE ER 63 63 89 149
GLIPIZIDE ER 63 60 89 115
DILTIAZEM 24HR CD 62 58 91 83
FENOFIBRATE 62 55 91 94
GALANTAMINE HBR 61 61 93 302
CLOTRIMAZOLE-BETAMETHASONE 61 57 93 127
ONGLYZA 60 56 95 211
TRICOR 60 58 95 96
INSULIN SYRINGE 59 53 97 102
COLCRYS 59 48 97 166
EVISTA 58 58 99 128
IPRATROPIUM-ALBUTEROL 57 57 100 99
DIOVAN HCT 57 57 100 63
NABUMETONE 57 54 100 259
CARVEDILOL 56 56 103 27
OXYCODONE HCL 56 52 S2 103 67
QUINAPRIL HCL 56 56 103 73
ENALAPRIL MALEATE 55 46 106 58
MELOXICAM 54 50 107 68
PRADAXA 54 54 107 188
PHENYTOIN SODIUM EXTENDED 53 53 109 152
TRIAMCINOLONE ACETONIDE 52 43 110 137
LACTULOSE 50 50 111 139
NOVOLOG FLEXPEN 50 34 111 212
LORAZEPAM 50 50 111 210
METHOCARBAMOL 50 26 R 111 321
FINASTERIDE 50 50 111 80
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 17, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.